3.1561

2.29% -0.0739

Sensus Healthcare Inc (SRTS)

Overview News Price History Option Chain Financials Discussions Forecast

Sensus Healthcare Inc stock is traded at $3.1561, with a volume of 3,884. It is down -2.29% in the last 24 hours and up +3.82% over the past month. Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.

Previous Close:

$3.23

Open:

$3.29

24h Volume:

3,884

Relative Volume:

0.10

Market Cap:

$51.96M

Revenue:

$22.53M

Net Income/Loss:

$-7.77M

P/E Ratio:

-6.6472

EPS:

-0.4748

Net Cash Flow:

$-740.00K

1W Performance:

+10.35%

1M Performance:

+3.82%

6M Performance:

-20.10%

1Y Performance:

-3.48%

1-Day Range:

$3.1561

$3.29

1-Week Range:

$2.85

$3.29

52-Week Range:

$2.66

$5.49

Sensus Healthcare Inc Stock (SRTS) Company Profile

Name

Sensus Healthcare Inc

Sector

Healthcare (1083)

Industry

Medical Devices (140)

Phone

561-922-5808

Address

851 BROKEN SOUND PARKWAY NW, BOCA RATON, FL

Employee

Twitter

@sensushealth

Next Earnings Date

2026-08-13

Latest SEC Filings

SRTS's Discussions on Twitter

Compare SRTS vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SRTS Sensus Healthcare Inc	3.1561	49.55M	22.53M	-7.77M	-740.00K	-0.4748
ABT Abbott Laboratories	114.68	198.01B	46.59B	5.41B	7.38B	3.0938
SYK Stryker Corp	330.90	130.41B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	92.28	120.48B	36.36B	4.84B	5.43B	3.7261
BSX Boston Scientific Corp	49.62	75.37B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	89.50	53.19B	6.30B	1.07B	1.09B	1.8406

Sensus Healthcare Inc Stock (SRTS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-06-26	Initiated	Alliance Global Partners	Buy
Jan-31-25	Initiated	Lake Street	Buy
Nov-15-24	Reiterated	Maxim Group	Buy
Feb-26-21	Upgrade	Northland Capital	Market Perform → Outperform
Dec-16-20	Downgrade	Northland Capital	Outperform → Market Perform
Aug-10-20	Upgrade	Alliance Global Partners	Neutral → Buy
Feb-14-20	Upgrade	Alliance Global Partners	Neutral → Buy
Nov-07-19	Downgrade	B. Riley FBR	Buy → Neutral
Jan-29-19	Downgrade	Northland Capital	Market Perform → Under Perform
Sep-26-18	Initiated	B. Riley FBR	Buy
Nov-03-17	Reiterated	Maxim Group	Buy
Jun-06-17	Initiated	Maxim Group	Buy
Aug-08-16	Initiated	Northland Capital	Outperform

View All

Sensus Healthcare Inc Stock (SRTS) Latest News

Aug 20, 2026

Sensus Healthcare Reports Q2 2026 Financial Results with Significant Revenue Decline - Intellectia AI

Aug 20, 2026

Aug 18, 2026

Sensus Healthcare revenues down 68.5% to USD 2.3M in Q2 2026 - Medical Buyer

Aug 18, 2026

Aug 17, 2026

A. G. P. Maintains Sensus Healthcare(SRTS.US) With Buy Rating, Cuts Target Price to $5.5 - Moomoo

Aug 17, 2026

Aug 15, 2026

Q2 2026 Sensus Healthcare Inc Earnings Call Transcript - GuruFocus

Aug 15, 2026

Aug 14, 2026

SRTS Maintained by Lake Street -- Price Target Lowered to $4.00 - GuruFocus

Aug 14, 2026

Sensus Healthcare, Inc. Q2 2026: Revenue $2.29M, EPS $(0.53) — 10-Q Summary - TradingView

Aug 14, 2026

Sensus Healthcare (NASDAQ:SRTS) Releases Quarterly Earnings Results, Misses Expectations By $0.41 EPS - MarketBeat

Aug 13, 2026

Earnings call transcript: Sensus Healthcare posts Q2 2026 miss, shares fall after hours - Investing.com

Aug 13, 2026

12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga

Aug 13, 2026

Sensus Healthcare Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 13, 2026

Full Transcript: Sensus Healthcare Q2 2026 Earnings Call - Benzinga

Aug 13, 2026

SENSUS HEALTHCARE ($SRTS) Releases Q2 2026 Earnings - Quiver Quantitative

Aug 13, 2026